Friger M - Search Results

1

Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel.

Reicher S, Ratzon R, Ben-Sahar S, Hermoni-Alon S, Mossinson D, Shenhar Y, Friger M, Lustig Y, Alroy-Preis S, Anis E, Sadetzki S, Kaliner E. Reicher S, et al. Among authors: friger m. Eur J Epidemiol. 2021 Jul;36(7):727-734. doi: 10.1007/s10654-021-00749-1. Epub 2021 Apr 21. Eur J Epidemiol. 2021. PMID: 33884542 Free PMC article.

2

Ethnic differences in the monthly variation of preeclampsia among Bedouin and Jewish parturients in the Negev.

Shental O, Friger M, Sheiner E. Shental O, et al. Among authors: friger m. Hypertens Pregnancy. 2010;29(3):342-9. doi: 10.3109/10641950902968692. Hypertens Pregnancy. 2010. PMID: 19943770 Free article.

3

Temporal trends in patient characteristics and survival of intensive care admissions with sepsis: a multicenter analysis*.

Dreiher J, Almog Y, Sprung CL, Codish S, Klein M, Einav S, Bar-Lavie Y, Singer PP, Nimrod A, Sachs J, Talmor D, Friger M, Greenberg D, Olsfanger D, Hersch M, Novack V; SEPSIS-ISR Group. Dreiher J, et al. Among authors: friger m. Crit Care Med. 2012 Mar;40(3):855-60. doi: 10.1097/CCM.0b013e318236f7b8. Crit Care Med. 2012. PMID: 22020241

4

In utero exposure to pre-eclampsia as an independent risk factor for long-term respiratory disease.

Nahum Sacks K, Friger M, Shoham-Vardi I, Sergienko R, Landau D, Sheiner E. Nahum Sacks K, et al. Among authors: friger m. Pediatr Pulmonol. 2020 Mar;55(3):723-728. doi: 10.1002/ppul.24659. Epub 2020 Jan 27. Pediatr Pulmonol. 2020. PMID: 31985889

5

Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19.

Hammerman A, Sergienko R, Friger M, Beckenstein T, Peretz A, Netzer D, Yaron S, Arbel R. Hammerman A, et al. Among authors: friger m. N Engl J Med. 2022 Mar 31;386(13):1221-1229. doi: 10.1056/NEJMoa2119497. Epub 2022 Feb 16. N Engl J Med. 2022. PMID: 35172072 Free PMC article.

6

Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years.

Arbel R, Sergienko R, Friger M, Peretz A, Beckenstein T, Yaron S, Netzer D, Hammerman A. Arbel R, et al. Among authors: friger m. Nat Med. 2022 Jul;28(7):1486-1490. doi: 10.1038/s41591-022-01832-0. Epub 2022 Apr 25. Nat Med. 2022. PMID: 35468276

7

Cancer incidence and risks in selected agricultural settlements in the Negev of Israel.

Avnon L, Oryan I, Kordysh E, Goldsmith J, Sobel R, Friger M. Avnon L, et al. Among authors: friger m. Arch Environ Health. 1998 Sep-Oct;53(5):336-43. doi: 10.1080/00039899809605718. Arch Environ Health. 1998. PMID: 9766478

8

Case-referent study on occupational risk factors for bladder cancer in southern Israel.

Carel R, Levitas-Langman A, Kordysh E, Goldsmith J, Friger M. Carel R, et al. Among authors: friger m. Int Arch Occup Environ Health. 1999 Aug;72(5):304-8. doi: 10.1007/s004200050379. Int Arch Occup Environ Health. 1999. PMID: 10447660

9

Unexpectedly low prevalence rates of IBS among adult Israeli Jews.

Sperber AD, Shvartzman P, Friger M, Fich A. Sperber AD, et al. Among authors: friger m. Neurogastroenterol Motil. 2005 Apr;17(2):207-11. doi: 10.1111/j.1365-2982.2005.00623.x. Neurogastroenterol Motil. 2005. PMID: 15787941

10

A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome?

Sperber AD, Shvartzman P, Friger M, Fich A. Sperber AD, et al. Among authors: friger m. Eur J Gastroenterol Hepatol. 2007 Jun;19(6):441-7. doi: 10.1097/MEG.0b013e32801140e2. Eur J Gastroenterol Hepatol. 2007. PMID: 17489053

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters